Welcome to the DC Clinical Trials Unit

Welcome to the DC CTU!

Uniting two clinical research sites right here in Washington, DC, the DC CTU is designed to address the HIV epidemic in the nation’s capital through cutting edge clinical and behavioral health research studies.

The CTU is comprised of two Clinical Research Sites (CRS): The Whitman-Walker Institute is a part of the AIDS Clinical Trials Group (ACTG), and The George Washington University is part of the HIV Prevention Trials Network (HPTN).

In concert with the NIH-funded networks, the DC CTU strives to implement cutting-edge HIV research in the DC metropolitan area. The DC CTU fosters new opportunities for HIV research by providing forums for collaboration between institutions and researchers and expanding opportunities for HIV prevention, treatment, and cure science in the nation's capital.

If you are interested in learning about the trials underway or more about the DC CTU, sign up for our new newsletter here. You can also learn more about our current studies and our community engagement efforts here on the pages of this website. 

This website is supported in part by award number UM1AI154466 from the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health. This statement acknowledges receipt of federal funding. The content, however, is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


Sign up to our newsletter and stay up to date


Thank you for subscribing to our newsletter.